欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Osenvelt	Human	denosumab	denosumab	EMEA/H/C/006157	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Eydenzelt	Human	aflibercept	aflibercept	EMEA/H/C/005899	Celltrion Healthcare Hungary Kft.	2025/02/12	Authorised
Kostaive	Human	zapomeran	COVID-19 sa-mRNA Vaccine	EMEA/H/C/006207	Seqirus Netherlands B.V.	2025/02/12	Authorised
Obodence	Human	denosumab	denosumab	EMEA/H/C/006424	Samsung Bioepis NL B.V.	2025/02/12	Authorised
Nemluvio	Human	nemolizumab	nemolizumab	EMEA/H/C/006149	Galderma International	2025/02/12	Authorised
Zefylti	Human	filgrastim	filgrastim	EMEA/H/C/006400	CuraTeQ Biologics s.r.o	2025/02/12	Authorised
Xbryk	Human	denosumab	denosumab	EMEA/H/C/006468	Samsung Bioepis NL B.V.	2025/02/12	Authorised
Emcitate	Human	tiratricol	tiratricol	EMEA/H/C/005220	Rare Thyroid Therapeutics International AB	2025/02/12	Authorised
Welireg	Human	belzutifan	belzutifan	EMEA/H/C/005636	Merck Sharp & Dohme B.V.	2025/02/12	Authorised
Beyonttra	Human	acoramidis	acoramidis hydrochloride	EMEA/H/C/006333	Bayer AG	2025/02/10	Authorised
Korjuny	Human	catumaxomab	catumaxomab	EMEA/H/C/005697	Atnahs Pharma Netherlands B.V.	2025/02/10	Authorised
Andembry	Human	garadacimab	garadacimab	EMEA/H/C/006116	CSL Behring GmbH	2025/02/10	Authorised
Hetronifly	Human	serplulimab	serplulimab	EMEA/H/C/006170	Accord Healthcare S.L.U.	2025/02/03	Authorised
Lazcluze	Human	lazertinib	lazertinib mesilate monohydrate	EMEA/H/C/006074	Janssen Cilag International NV	2025/01/20	Authorised
Kavigale	Human	sipavibart	sipavibart	EMEA/H/C/006291	AstraZeneca AB	2025/01/20	Authorised
Gohibic	Human	vilobelimab	vilobelimab	EMEA/H/C/006123	InflaRx GmbH	2025/01/13	Authorised
Baiama	Human	aflibercept	aflibercept	EMEA/H/C/005980	Formycon AG	2025/01/13	Authorised
Ahzantive	Human	aflibercept	aflibercept	EMEA/H/C/006607	Formycon AG	2025/01/13	Authorised
Siiltibcy	Human	Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10)	Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10)	EMEA/H/C/006177	Serum Life Science Europe GmbH	2025/01/13	Authorised
Augtyro	Human	repotrectinib	repotrectinib	EMEA/H/C/006005	Bristol-Myers Squibb Pharma EEIG	2025/01/13	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-